General Information
Revision date
2022-12-14
Product name
Promethazine Hydrochloride Suppositories USP 12.5 mg
Manufacturer Name
Annora Pharma Private Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
According to Article 1, item 5 (a) of CLP Regulation (EC) or mixture
Hazard statements
This product presents minimal hazards in the workplace due to form of product. Handling of the unwrapped suppository may result in skin irritation or allergic reactions in persons susceptible to Promethazine Hydrochloride, other phenothiazines, or any of the other ingredients in this product. May be harmful if accidentally ingested. Therapeutic use of Promethazine Hydrochloride can cause adverse symptoms on the respiratory, cardiovascular, and central nervous systems. There is some evidence that the active ingredient may cause harm to the fetus. Reactivity Hazards This product is not reactive Flammability Hazards This product is combustible and may ignite if involved in a fire. When involved in a fire, this material may decompose and produce irritating vapors and toxic compounds (including carbon, nitrogen and silicon oxides).
Environmental hazards
Large quantities released to the aquatic and terrestrial environment may have an adverse effect. Emergency Considerations Emergency responders should wear appropriate protection for situation to which they respond.
